1. Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
   Lisi Zeng et al, 2022, Frontiers in Oncology CrossRef
2. Silica-Coated Metal Chelating-Melanin Nanoparticles as a Dual-Modal Contrast Enhancement Imaging and Therapeutic Agent
   Soojeong Cho et al, 2017, ACS Applied Materials & Interfaces CrossRef
3. Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials
   Minhan Jiang et al, 2023, Frontiers in Oncology CrossRef
4. A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
   Markus W. Löffler et al, 2019, Frontiers in Immunology CrossRef
5. Radiofrequency Thermal Ablation of Hepatocellular Carcinoma Liver Nodules Can Activate and Enhance Tumor-Specific T-Cell Responses
   Alessandro Zerbini et al, 2006, Cancer Research CrossRef
6. Impact of Endoluminal Radiofrequency Ablation on Immunity in Pancreatic Cancer and Cholangiocarcinoma
   Jana Jarosova et al, 2022, Biomedicines CrossRef
7. Recent Advances in Thermal Treatment Techniques and Thermally Induced Immune Responses Against Cancer
   J. F. Bai et al, 2014, IEEE Transactions on Biomedical Engineering CrossRef
8. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights
   Maria Tampaki, 2015, World Journal of Hepatology CrossRef
9. CEUS-Based Radiomics Can Show Changes in Protein Levels in Liver Metastases After Incomplete Thermal Ablation
   Haiwei Bao et al, 2021, Frontiers in Oncology CrossRef
10. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma
    Yang Zhao et al, 2024, Frontiers in Immunology CrossRef
11. The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy
    Yuxin Duan et al, 2023, BioScience Trends CrossRef
12. Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
    Cheng Zhong et al, 2021, Frontiers in Oncology CrossRef